Latest Period
Q1 2026
Security Snapshot
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) Institutional Ownership
CUSIP: 50127T109
13F Institutional Holders and Ownership History from Q4 2015 to Q1 2026
Institutions Reporting
215
Shares (Excl. Options)
84,373,332
Price
$8.13
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- KURA on Nasdaq
- Shares outstanding
- 88,321,513
- Price per share
- $9.47
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 84,373,332
- Total reported value
- $686,045,039
- % of total 13F portfolios
- 0%
- Share change
- -1,152,867
- Value change
- -$12,209,022
- Number of holders
- 215
- Price from insider filings
- $9.47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 50127T109.
- 215 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 211 to 215 between Q4 2025 and Q1 2026.
- Reported value moved from $885,604,426 to $686,045,039.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 215 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 50127T109:
Significant Owners of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 10% | +31% | $76,791,609 | +$24,465,506 | 8,677,018 | +47% | BVF PARTNERS L P/IL | 30 Sep 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.4% | +39% | $49,222,110 | +$15,381,900 | 7,561,000 | +45% | SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar 2025 |
| BlackRock, Inc. | 7.8% | -24% | $41,202,116 | -$10,448,902 | 6,329,050 | -20% | BlackRock, Inc. | 31 Mar 2025 |
| STATE STREET CORP | 5.7% | $45,218,095 | 4,931,090 | STATE STREET CORPORATION | 31 Dec 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $36,006,242 | 4,428,812 | Vanguard Capital Management | 31 Mar 2026 | |||
| EcoR1 Capital, LLC | 4.8% | $23,520,000 | 4,200,000 | EcoR1 Capital, LLC | 30 Jun 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 4.9% | $26,070,011 | 4,004,610 | RA Capital Management, L.P. | 31 Mar 2025 | |||
| ARMISTICE CAPITAL, LLC | 4.2% | -24% | $32,839,440 | -$10,548,000 | 3,736,000 | -24% | Armistice Capital, LLC | 31 Mar 2026 |
As of 31 Mar 2026, 215 institutional investors reported holding 84,373,332 shares of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA). This represents 96% of the company’s total 88,321,513 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 9,637,531 | +7% | 0% | $78,353,125 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.7% | 8,575,422 | 0% | 1.9% | $69,718,181 |
| BVF INC/IL | 9.6% | 8,445,769 | -2% | 2.2% | $68,664,102 |
| STATE STREET CORP | 5.1% | 4,511,891 | -8.5% | 0% | $36,681,674 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 3,785,685 | 0% | 0% | $30,777,619 |
| ARMISTICE CAPITAL, LLC | 4.2% | 3,736,000 | -24% | 1% | $30,373,680 |
| Prosight Management, LP | 3.8% | 3,356,700 | +33% | 4.5% | $27,289,971 |
| Deep Track Capital, LP | 3% | 2,643,542 | 0.44% | $21,491,996 | |
| AQR CAPITAL MANAGEMENT LLC | 2.4% | 2,124,480 | -31% | 0.01% | $17,272,026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 2,034,276 | +0.28% | 0% | $16,542,370 |
| Qube Research & Technologies Ltd | 1.9% | 1,636,733 | +23% | 0.02% | $13,306,639 |
| RENAISSANCE TECHNOLOGIES LLC | 1.8% | 1,582,568 | -14% | 0.02% | $12,866,278 |
| MILLENNIUM MANAGEMENT LLC | 1.8% | 1,565,143 | -1.2% | 0.01% | $12,724,613 |
| ALETHEA CAPITAL MANAGEMENT, LLC | 1.7% | 1,529,369 | +7.5% | 6.7% | $12,433,770 |
| GOLDMAN SACHS GROUP INC | 1.6% | 1,433,471 | -22% | 0% | $11,654,119 |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 1,425,945 | +32% | 0% | $11,590,675 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.4% | 1,230,802 | 0% | 0% | $10,006,420 |
| BANK OF AMERICA CORP /DE/ | 1.4% | 1,230,131 | +46% | 0% | $10,000,965 |
| MORGAN STANLEY | 1.3% | 1,163,977 | -16% | 0% | $9,463,138 |
| NAN FUNG TRINITY (HK) LTD | 1.2% | 1,064,880 | +10% | 0.95% | $8,657,474 |
| UBS Group AG | 1.2% | 1,040,233 | -1.9% | 0% | $8,457,094 |
| Pale Fire Capital SE | 0.97% | 857,474 | +90% | 0.61% | $6,971,264 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.91% | 800,597 | +29% | 0.01% | $6,508,854 |
| NORTHERN TRUST CORP | 0.86% | 756,273 | +4.6% | 0% | $6,148,500 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.78% | 690,817 | -2.8% | 0% | $5,616,342 |
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 84,373,332 | $686,045,039 | -$12,209,022 | $8.13 | 215 |
| 2025 Q4 | 85,250,268 | $885,604,426 | +$20,117,899 | $10.39 | 211 |
| 2025 Q3 | 83,884,309 | $742,481,432 | +$26,729,034 | $8.85 | 197 |
| 2025 Q2 | 82,161,271 | $474,076,451 | +$3,886,077 | $5.77 | 180 |
| 2025 Q1 | 80,481,583 | $531,240,145 | -$1,742,391 | $6.60 | 183 |
| 2024 Q4 | 78,800,102 | $686,302,860 | -$217,671,932 | $8.71 | 184 |
| 2024 Q3 | 82,360,607 | $1,606,956,703 | +$4,044,498 | $19.54 | 178 |
| 2024 Q2 | 80,489,635 | $1,657,260,003 | -$4,649,743 | $20.59 | 173 |
| 2024 Q1 | 80,704,151 | $1,721,386,349 | +$47,334,824 | $21.33 | 162 |
| 2023 Q4 | 78,750,714 | $1,132,429,796 | +$48,405,539 | $14.38 | 138 |
| 2023 Q3 | 75,320,060 | $686,894,075 | -$2,210,555 | $9.12 | 131 |
| 2023 Q2 | 75,143,461 | $795,074,726 | +$20,118,060 | $10.58 | 147 |
| 2023 Q1 | 72,452,228 | $885,285,317 | +$27,367,401 | $12.23 | 140 |
| 2022 Q4 | 70,164,281 | $870,596,716 | -$25,367,145 | $12.41 | 139 |
| 2022 Q3 | 71,584,721 | $977,803,865 | -$10,119,008 | $13.66 | 144 |
| 2022 Q2 | 68,658,415 | $1,258,498,156 | +$54,233,601 | $18.33 | 142 |
| 2022 Q1 | 65,777,551 | $1,057,605,942 | +$39,092,796 | $16.08 | 142 |
| 2021 Q4 | 64,108,565 | $897,784,334 | -$107,625,141 | $14.00 | 143 |
| 2021 Q3 | 66,738,474 | $1,250,027,023 | -$22,664,956 | $18.73 | 149 |
| 2021 Q2 | 67,619,494 | $1,409,907,095 | -$33,759,405 | $20.85 | 163 |
| 2021 Q1 | 68,584,982 | $1,942,401,972 | +$106,818,236 | $28.27 | 162 |
| 2020 Q4 | 65,052,975 | $2,124,984,562 | +$353,968,960 | $32.66 | 192 |
| 2020 Q3 | 53,818,393 | $1,648,931,451 | +$50,643,099 | $30.64 | 160 |
| 2020 Q2 | 52,442,231 | $855,540,393 | +$213,208,168 | $16.30 | 129 |
| 2020 Q1 | 39,802,987 | $394,470,751 | +$5,045,270 | $9.95 | 113 |
| 2019 Q4 | 38,979,999 | $536,059,777 | -$17,580,300 | $13.75 | 125 |
| 2019 Q3 | 40,174,979 | $609,372,943 | +$18,475,235 | $15.17 | 114 |
| 2019 Q2 | 38,684,419 | $761,718,678 | +$133,021,751 | $19.69 | 121 |
| 2019 Q1 | 32,044,753 | $531,121,734 | -$3,584,064 | $16.59 | 100 |
| 2018 Q4 | 32,415,330 | $454,789,379 | -$2,761,213 | $14.04 | 95 |
| 2018 Q3 | 30,235,029 | $529,138,565 | +$7,587,244 | $17.50 | 112 |
| 2018 Q2 | 29,714,074 | $540,689,653 | +$112,569,821 | $18.20 | 108 |
| 2018 Q1 | 23,570,284 | $441,929,475 | +$77,404,250 | $18.75 | 98 |
| 2017 Q4 | 19,535,236 | $298,877,651 | +$581,471 | $15.30 | 73 |
| 2017 Q3 | 19,416,540 | $290,234,810 | +$128,771,717 | $14.95 | 64 |
| 2017 Q2 | 10,813,395 | $100,551,904 | +$4,771,007 | $9.30 | 42 |
| 2017 Q1 | 10,310,503 | $90,718,000 | +$4,182,413 | $8.80 | 34 |
| 2016 Q4 | 9,877,148 | $58,241,000 | +$736,496 | $5.90 | 29 |
| 2016 Q3 | 9,748,853 | $60,931,000 | +$2,850,289 | $6.25 | 25 |
| 2016 Q2 | 9,319,042 | $25,248,000 | -$3,677,975 | $2.71 | 25 |
| 2016 Q1 | 10,225,954 | $41,413,000 | -$249,669 | $4.05 | 20 |
| 2015 Q4 | 10,246,869 | $86,073,000 | +$80,324,000 | $8.40 | 14 |